Half of UK patients with rheumatoid arthritis are prescribed oral glucocorticoid therapy in primary care: a retrospective drug utilisation study
Rachel Black(The University of Sydney), William G Dixon(Manchester Academic Health Science Centre), Rebecca M. Joseph(Manchester Academic Health Science Centre), Benjamin Brown(Farr Institute), Mohammad Movahedi(University Health Network), Mark Lunt(University of Cambridge)
Cited by 31
Related Papers
Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR)
|Annals of the Rheumatic Diseases|2009|708
Global, regional, and national burden of rheumatoid arthritis, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021
|The Lancet Rheumatology|2023|584
Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force
|Annals of the Rheumatic Diseases|2016|331
Bone Density Reduction in Various Measurement Sites in Men and Women with Osteoporotic Fractures of Spine and Hip: The European Quantitation of Osteoporosis Study
|Calcified Tissue International|1999|98
Risk of mortality in patients with giant cell arteritis: A systematic review and meta-analysis
|Seminars in Arthritis and Rheumatism|2016|83